Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
NCT03770702

Statins and ARBs on Rheumatoid Activity

Led by Sherief Abd-Elsalam · Updated on 2018-12-10

45

Participants Needed

1

Research Sites

426 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

CONDITIONS

Official Title

Statins and ARBs on Rheumatoid Activity

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Rheumatoid arthritis
Not Eligible

You will not qualify if you...

  • Pregnant or lactating
  • Hepatic or renal impairment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Sherief Abd-Elsalam

Tanta, Egypt, 35111

Actively Recruiting

Loading map...

Research Team

S

Sherief Abd-Elsalam, Ph D

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Statins and ARBs on Rheumatoid Activity | DecenTrialz